A nationwide study from Denmark presented at this year’s European Congress on Obesity (ECO2026) in Istanbul, Turkey, shows that use of semaglutide (Wegovy) for weight management is associated with a 7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results